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Summary: 2-(3-Methyl-cinnamyl-hydrazono)-propionate stimulated glucose oxidation in human mono-
nuclear leukocytes and the Stimulation was similar to that by concanavalin A. Both substances must affect
glucose metabolism at two sites, the first site being before the pyruvate dehydrogenase Step because of the
increase of lactate plus pyruvate concentration. The second site is related to pyruvate oxidation.
The hydrazone inhibited the conversion of palmitate to CO2. This effect could have caused an activation of
the pyruvate dehydrogenase complex, resulting from a decreased acetyl-CoA/CoA ratio. Concanavalin A
did not influence fatty acid oxidation. Both substances did not affect the CO2 forrnation from acetate.
Mononuclear leukocytes appear to be a suitable model f r the investigation of the influence of hypoglycaemic
substances on glucose and fatty acid metabolism in living human cells.
Introduction Human mononuclear blood cells have become in-
„ j · · - j i_ i_ r· j i creasingly useful f r the study of insulin receptorsHydrazonopropiomc acids have been found to lower ,_ ' , . , -. - . „*u u-i Λ i ~ ' ' Γ ' V. . . ' , ' (7—10) and vanous metabohc pathways, especmllythe blood glucose concentration in vanous laboratory : . ," .' , ,. ,44 * —,. ' ° ON _ /0 ~f , t . , « j \ m glucose and fatty acid metabolism (11 — 13). Theammals (1—3). 2-(3-Methyl-cmnamyl-hydrazono)- . _ , , a , / j r A, Λ, , ./χΛ-ΑττηΝ · -j j i. * · entire Embden-Meyerhof pathway and the completepropionate (MCHP) is considered to be most promis- ., . f f 4 J .. . , ,. . . . .. ,: ;' - i i ·,. Γ - t_ oxidation of fatty acids mcludmg the citnc acid cyclemg s a potential oral antidiabetic substance among . , ' /A λ 4 CN \, . ,j . r - - . j operate in lymphocytes (14, 15). Many mborn errorsvanous derivatives of hydrazono-propionate tested £ t I? ^ -\ * i. r i~ t u
f ~ r r of glucose and fatty acid metabolism have also been
so lar (4, 5). detected in these blood cells (16-18). HL 60 leukae-
The mechanism of action appears to be multifactorial mic cell lines have been shown to be unable to grow
because hepatic gluconeogenesis and jejunal glucose in an insulin-free medium (19). The raised level of
uptake are influenced by these cqmpounds. Recently activated T lymphocytes precedes the earliest abnor-
we have found that the glucose consumption by hemi- malities of glucose tolerance in insulin-dependent dia-
diaphragms of rats is stimulated by 2^(3-methykcin- betes (20). Hence, it appears reasonable to study the
namyl-hydrazono)-propi nate (6). However, all ex- action of pharmacologically effective substances on
periinerits have so far been performed in anirnal these pathways in mononuclear leukocytes. They rep-
models. resent easily accessible living cells which can be ob-
-. . tainedfrom he^lthy anddiseasedpersons, thus avoid-
*) Part VI see 1. c. (30). ing the use of laboratory animals.
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We have therefore investigated whether glucose con-
sumption is also influenced by 2-(3-methyl-cinnamyl-
hydrazono)-propionate in human mononuclear leu-
kocytes.
Since lymphocytes have been widely used to study
the Stimulation of glucose oxidation by concanavalin
A (21, 22), this compound was included in the present
experiments for purposes of comparison.
Materials and Methods
Materials
Sodium metrizoate-Ficoll (Lymphoprep, cat. No. 350031, den-
sity 1.077) was purchased from Molter (D-6900 Heidelberg),
Heparin Novo (5000 IU · ml""1) from Novo Industry Pharma-
zeutika (D-6500 Mainz).
2-(3-Methyl-cinnamyl-hydrazono)-propionate was generously
provided by Prof. Dr. F. H. Schmidt and Dr. H. K hnle
(Boehringer Mannheim GmbH, D-6800 Mannheim). On the
day before the experiment 2-(3-methyl-cinnamyl-hydrazono)-
propionate was freshly dissolved in 100 ml Krebs-Ringer bicar-
bonate solution (pH = 7.4) and treated with ultrasound for
about 30 minutes to achieve a clear solution.
All enzymes, coenzymes and fatty acid-free bovine albumin
(cat. No. 775 835) were purchased from Boehringer Mannheim
GmbH (D-6800 Mannheim), Hionic Fluor (cat. No. 6013319)
from Packard Instruments International S. A. (CH-Z rich).
Concanavalin A from Serva AG (D-6900 Heidelberg, cat. No.
27648, 102000) and all other chemicals were from E. Merck
AG (D-6100 Darmstadt).
Labelled compounds were obtained from Amersham Buchler
(D-3300 Braunschweig): sodium [l-14C]acetate (code No. CFA.
13; 2.18 GBq · mmol-1), sodium D, £-[l-14C]lactate (c°de CFA.
89; 2.0 GBq -mmo!"1), [l-14C]pyruvic acid (code CFA. 703;
381 MBq · mmo!'1), Z)-[U-14C]glucose (code CFA. 96; 10.4
GBq · mmol-1). [l-14C]Palmitic acid (code No. CFA. 23; 2.15
GBq · mmol"·1) was diluted l: 50 in Krebs-Ringer bicarbonate
solution (pH 7.4) containing 39 g · l"1 albumin and mixed one
hour at 37 °C with a magnetic stirrer.
Preparation of mononuclear leukocytes
Mononuclear leukocytes were isolated accordi g to Fink et al.
(23) on a Lymphoprep density gradient from about 80 ml
freshly drawn venous blood (20 ml plastic syringes were rinsed
with Heparin Novo). The mononuclear leukocyte fraction con-
tained on average about 96% lymphocytes and 4% monocytes.
The blood was taken from healthy members of the hospital
staff at 7.30 a. m. after their usual breakfast. The haemogram
(performed with a Technicon H 6000 analyser), blood glucose
and HbA! concentration were in the reference r nge. The cell
fraction was washed twice with phosphate-buffered sodium
Chloride solution (13.7 mmol/1, pH 7.2) containing 2g -l-1
bovine albumin and then suspended in 10 ml Krebs-Ringer
bicarbonate solution containing 2g -l-1 albumin. The cells
were counted with a Sysmex cc-700 analyser according to the
manufacturers' instructions (TOA Medical Electronics Co, D-
2000 Hamburg). The cells were stained with trypan blue; s a
sign of viability more than 98% of cells excluded the dye.
Mononuclear leukocyte Suspension (700 μΐ, containing about
3 χ l O6 cells) were incubated in a 50 ml Erlenmeyer flask at
37°C (shaking cycles 134 min-1) with 700 μΐ Krebs-Ringer*
bicarbonate solution containing 2 or 20 g · 1~1 bovine albumin
(pH = 7.4), 50 μΐ Substrate solution and 50 μΐ iabelled Substrate
solution. The experiments were started by adding the leukocyte
Suspension. Then the flasks were closed with a rubber cap. The
cap carried a glass Container for the later addition of sodium
hydroxide.
14CO2 collection ( f
After incubation of the leukocyte fraction with Iabelled Sub-
strates for 60 or 180 minutes, the experiment was terminated
by injecting 0.5 ml perchloric acid (0.6 mol · l""1) and 0.5 ml
NaOH (l mol · 1-I) through the rubber cap and continuing the
incubation for one hour. The glass Containers carrying the
NaOH were then transferred from the rubber cap into the
scintillation Cocktail (10.7 ml Hionic Fluor) and counted in a
Beckman LB 1801 liquid scintillation counter (Beckman Instru-
ments, D-8000 Munich). Water Condensed at the outer sufface
of the glass Container was carefully wiped off.
Determination of metabolite concentrations
For the determination of metabolite concentrations the reaction
mixture was centrifuged (10 min, 5000g) after the addition f
0.5 ml perchloric acid (0.6 mol -l"1); the supernatant was
neutralised with K2CO3. Ghicose and glycogen were determined
with the method of Keppler & Decker (24), pyruvate according
to Lamprecht & Heinz (25) and lactate with the monotest from
Boehringer Mannheim (cat. No. 149993).
Statistical evaluation
The mean values are given with their Standard deviations. The
means are compared with each other by the Wilcoxon signed
rank test or paired t-test. DifFerences are considefed to be
significant if p < 0.05. The number of experiments was related
to the number of cell preparations from various individuals.
Results
The formation of CO2 from [U-14C]ghieose was
stimulated by 2-(3-methyl-cinn myl-hydrazono)*pro-
pionate in human mononuclear leukocytes. The max-
imal effect was obtained with a concentration of 0.2
mmol/1 (fig. 1). At higher concentrations the activa^
tion declined. The stimulatory effect of 2^(3-methyl-
cinnamyl-hydrazono)-propionate (tab. 1) was re-
duced in the presence of higher glucose (10 mna l/l)
and albumin concentrations (20 g/l).
The mononuclear leukocytes (1Ό10 cells) consumed
447 μπιοΐββ glucosyl units in 3 hours. This rate was
elevated in the presence of 2-(3-methyl-cinnamyl-hy-
draz no)-propi nate to 792 umoles (tab, 2). The py-
ruvate production was distinetly increased and the
lactate formation not sigmficantly affected by 2-(3-
methyl-cinnamyl-hydrazono)=propipnate (tab. 2).
Thereforej the lactate/pyruvate ratio decreased in the
perchloric acid extract of the incubatiori medium
from 15 to 2 in the presence of 2-(3-metfayl-cirManiyl-
hydrazono)-propionate.
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Fig. 1. The influence of 2-(3-methyl-cinnamyl-hydrazono)-pro-
The 14C transfer from uniformly labelled glucose to
CO2 was also stimulated by concanavalin A (tab. 2).
When 2-(3-methyl-cinnamyl-hydrazono)-propionate
and concanavalin A were added together, each in a
concentration causing maximal Stimulation, additive
effects on the consumption of glucosyl units were
not observed (tab. 2). In contrast to 2-(3-methyl-
cinnamyl-hydrazono)-propionate, the addition of
concanavalin A caused an increase of lactate, leading
to an approximate 20-fold increase in the lactate/
pyruvate ratio (tab. 2).
In the presence of labelled pyruvate (l .0 mmol/1) or
lactate (2.0 mmol/1) the CO2 release was also stimu-
lated by 2-(3-methyl-cinnamyl-hydrazono)-propion-
ate and concanavalin A (tab. 3) with slight additive
effects of both compounds. When labelled lactate or
pyruvate were used together with unlabelled glucose
(2.0 mmol/1) only 2-(3-methyl-cinnamyl-hydrazono)-
1 pionate on CO2 formation irom glucose in human lym- propionaie mcreasea ine ^U2 lormation, wnereas
phocytes. Incubation time: 3 hours. concanavalin A was without effect and even pre-
f _ χ _ s, n - . vented the Stimulation by 2-(3-methyl-cinnamyl-hy-
drazono)-propion#te (tab. 4).
Tab. 1 . The influence of 2-(3-methyl-cinnamyl-hydrazono)-propionate (MCHP)
CO2 in human mononuclear leukocytes. Figures are mean values in
preparations with Standard deviation. Incubation: 3 h at 37 °C.
( Albumin
r Glucose
«. 14CO2 formation, control




(g · l'1) 2
(mmol · l"1) <0.1
(kBq per assay) 24.7
(MBq/1010 cells) 3.95 ±
(MBq/1010 cells) 6.38 ±




on the transfer of 14C from
MBq per 1010 cells from n
20
24.7
1.32 5:98 + 3.00
















*) paired t-test between control and "MCHP"-values
Tab. 2. The influence of 2-(3-methyl-cinnamyl-hydrazono)-prppionate (MCHP, 0.2 mmol/1) and concanavalin A (0.65 μηιοΐ/ΐ)
on the glucose consumption and on the pyruvate, lactate and CO2 formation of human leukocytes. The glucose
concentration in the reaction mixture was 2 mmol/1 ([U-14C]glucose 24.6 kBq).
The figures are mean values (μιηοΐ per 1010 cells) frorn 5 experiments with Standard deviation. Incubation: 3 h at 37 °C.
Coritrol
Glycosyl units1) consumed 447 ± 145
(μιηοΙ/1010 cells)
Lactate f raied 669 ± 56
(μπιρ1/1010 ceUs)
Pyruvate formed 45 + 1 5
(Mmol/1010 cells)


















J) The difference between the sum of glucose and glycogen-glycosyl units at 180 minutes and at the beginning of the incubation
period.
* This value differs significantly from its corresponding control value.
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The oxidation of long-chain fatty acids to CO2 s
measured by the 14C transfer from [l-14C]labelled
palniitate to CO2 was reduced to 27% by 0.2 mmol/1
2-(3-methyl-cinnamyl-hydrazono)-propionate (tab.
1), whereas the metabolism of acetate to CO2 was
not affected (tab. 5). Concanavalin A did not influ-
ence the oxidation of palmitate nor of acetate.
Discussion
2-(3-Methyl-cinnamyl-hydrazono)-propionate and
concanavalin A stimulated the conversion of glucose
to CO2 s indicated by the increased 14C transfer
from uniformly labelled glucose (tab. 2).
Both substances must have affected the glucose
metabolism at least at two sites: one is probably
related to the pyruvate dehydrogenase coraplex and
the other site is before this step. Since the 14C transfer
was also stimulated from [l-14C]pyruvate s well s
from [l-14C]lactate it can be assumed that the hydra-
zonopropionate affected either pyruvate transport
into the mitochondria or the pyruvate dehydrqgenase
complex. It is improbable that a later step of the
pyruvate metabolism was involved because the CO2
formation from [l-14C]acetate was not influenced by
both compound$. This finding excludes an uiicou-
pling effect. It has been shown that carbonylcyanide
chlorophenylhydrazone (CCCP), an uncoupler of x-
idative phosphorylation, stimulates the oxidation of
both [l-14C]pyruvate and [l-14C]acetate (26).
Tab. 3. The influence of 2(3-methyl-cinnamyl-hydrazono)-propionate (MCHP, 0.2 mmpl/1) and concanavalin A (0.7 μχηοΐ/ΐ, 72
mg/1) on CO2 formation in the presence of [1-14C] pyruvate (1.5 kBq, 1.0 mmol/1) and [l-14C]lactate (3.7 kBq, 2.0 mmol/1)
in mononuclear leukocytes. The figures are mean values per l O10 cells with Standard deviation. Incubation: 3 h at 37 °C.








































* this value differs signiflcantly from its corresponding control value
Tab. 4. The influence of 2(3-methyl-cinnamyl-hydrazono-propionate (MCHP, 0.2 mmol) and concanavalin A (0.7 μιηοΐ/ΐ, 72 mg/
1) on the transfer of 14C from [l-14C]pyruvate (1.5 kBq, 3.9 nmol) and [l-I4C]lactate (3.7 kBq, 3.9 nmol) into CO2 in the
presence of 2.0 mmol - l"1 glucose by human mononuclear leukocytes. Albumin: 2 g · l"1. Figures are mean values in







































* this value differs significantly from its corresponding control value
Tab. 5. The influence of 2(3-methyl-cinnamyl-hydrazono)-propionate (MCHP, 0.2 mmol/1) and concanavalin A (0.7 uinol/1, 72
mg/1) on CO2 formation from [l-14C]acetate (1.78 kBq; 1.0 mmol · l"1) and [1-14C] palmitate (7.4 kBq). The figufe$ are
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A direct effect of 2-(3-methyl-cinnamyl-hydrazono)-
propionate on the pyruvate dehydrogenase in mito-
chondrial extracts from guinea pig livers has been
excluded (27). The activity of the pyruvate dehydro-
genase is regulated by the degree of phosphorylation
of the -subunit of the enzyme. The phosphorylated
form of the enzyme is inactive while the dephosphor-
ylated form is active. Regulation of the phosphoryla-
tion occurs through the action of a kinase and a
phosphatase contained within the multienzyme com-
plex. Activation of the pyruvate dehydrogenase is
obtained if the kinase reaction is reduced, e. g. by
a decrease of mitochondrial concentration ratios of
NADH/NAD+, acetyl-CoA/CoA or ATP/ADP (28,
29). All three ratios are influenced by the rate of fatty
acid oxidation. If this is inhibited lower ratios can be
expected.
The cytoplasmic concentration ratio of NADH/
NAD+ was reduced in human mononuclear leuko-
cytes by 2-(3-methyl-cinnamyl-hydrazono)-propio-
nate, äs indicated by the lactate/pyruvate ratio. The
hepatic acetyl-CoA/CoA ratio was found to be re-
duced in the presence of 2-(3-methyl-cinnamyl-hydra-
zono)-propionate. This suppression was explained by
an Inhibition of the fatty acid oxidation, which has
been shown to occur in the perfused guinea pig liver
(3). In human mononuclear leukocytes the oxidation
of palmitate was also significanüy reduced by 2-(3-
methyl-cinnamyl-hydrazono)-propionate (tab. 5) and
could have led to a low acetyl-CoA/CoA ratio.
The primary event in the mechanism of hypoglycae-
mia produced by 2-(3-methyl-cinnamyl-hydrazono)-
propionate could be an Inhibition of long-chain fatty
acid oxidation which depends on the carnitine acyl-
carnitine translocase System (30). Further effects can
then be interpreted äs secondafy phenomena: inhibi^
tion of hepatic gluconeogenesis, jejunal Inhibition of
glucose uptake, Stimulation of glucose oxidation in
the diaphragm (6) and in mononuclear leukocytes.
Presumably the Inhibition of gluconeogenesis is the
major cause of the hypoglycaemia observed in fasted
animals, whereas the other effects of 2-(3-methyl-
cinnamyl-hydrazono)-propionate may be additional
factors in lowering the blood glucose concentration.
The effect of 2-(3^methyl-cinaamyl-hydrazono)-pro-
pionate on Rändle*s glucose-fatty acid cycle (31) ap-
pears to be similar to that observed with other inhibi-
tors of fatty acid oxidation (31, 32). The glucose-
fatty acid cycle also operates in mononuclear leukocy-
tes (to be reported in a subsequent paper). The mech-
anism of action suggested for 2-(3-methyl-cinnamyl-
hydrazono)-propionate seems to be different from
that of concanavalin A because the latter substance
did not influence the oxidation of palmitate.
In the presence of 2 mmol -l"·1 unlabelled glucose,
CO2-formation from [l-14C]-pyruvate was stimulated
by 2-(3-methyl-cinnamyl-hydrazono)-propionate but
not by concanavalin A, although the lactate concen-
tration was significantly increased by the latter com-
pound. No explanation can be offered for this obser-
vation.
The concentration of lactate plus pyruvate was sig-
nificantly increased in the presence of 2-(3-methyl-
cinnamyl-hydrazono)-propionate or concanavalin A
(tab. 2). Therefore, the activation of the pyruvate
oxidation äs indicated by the CO2 formation (tab. 3)
cannot completely explain the effect of both com-
pounds on the glucose metabolism. It must be as-
sumed that the metabolic flow rate between glucose
and pyruvate is also stimulated. Apparently the pyru-
vate formed cannot then be oxidized fast enough,
and therefore tends to accumulate.
Several authors have suggested that Stimulation of
glycolysis by concanavalin A results from the coordi-
nated activation of plasma-membrane glucose trans-
port and phosphöfructose kinase in thymocytes (33,
34). Furthermore, the mitogen caused a specific in-
crease in pyruvate oxidation and a disproportionately
large conversion of glucose into lactate (36). Brand
et al. (22, 36) have observed that the ratio of 14CO2
released from [l-14C]glucose to that from [6-14C]glu-
cose is both small and similar in the absence and
presence of concanavalin A, suggesting that glucose
metabolism via the oxidative segment of the pentose
pathway is not enhanced relative to the tricarboxylic
acid cycle oxidations in mitogen-activated rat thymo-
cytes.
Concanavalin A is a well-known stimulator of mito-
genesis. The hydrazonopropionate was without any
stimulatory effect up to a concentration of l .0 mmol
l"1 (38) using human mononuclear leukocytes in the
mitogen Stimulation assay (38).
In conclusion, the effect of 2-(3-methyl-cinnamyl-
hydrazono)-propionate on the oxidation of glucose
and palmitate in leukocytes was similar to that ob-
served in rat hemidiaphragm. The experimental
model of mononuclear leukocytes, representing more
than 95% lymphocytes, appears to be well suited for
investigating the effect of hypoglycaemic substances
on glucose and fatty acid metabolism in human cells.
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